亚洲社会药学
亚洲社会药学

快速检索 年期检索

›› 2014, Vol. 9 ›› Issue (2): 60-63.doi:

• 论文 • 上一篇    下一篇

Biosimilars: Current Status and Countermeasures

LI Yan-ru, TIAN Li-juan   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2014-06-20 发布日期:2014-06-20
  • 通讯作者: TIAN Li-juan

Biosimilars: Current Status and Countermeasures

LI Yan-ru, TIAN Li-juan   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2014-06-20 Published:2014-06-20
  • Contact: TIAN Li-juan

摘要： Objective To study the current status of biosimilars, and to explore strategies for the healthy development of biosimilars in China.
Methods Literature review was conducted to summarize the status of biosimilars both at home and abroad. Results and Conclusion
The development of biosimilars in China is not yet mature compared with the advanced countries. Support from both companies and
the state is needed to promote the development of biosimilars in China.

关键词: biosimilar, current status, development strategy

Abstract: Objective To study the current status of biosimilars, and to explore strategies for the healthy development of biosimilars in China.
Methods Literature review was conducted to summarize the status of biosimilars both at home and abroad. Results and Conclusion
The development of biosimilars in China is not yet mature compared with the advanced countries. Support from both companies and
the state is needed to promote the development of biosimilars in China.

Key words: biosimilar, current status, development strategy

版权所有 © 2019 《亚洲社会药学》

本系统由北京玛格泰克科技发展有限公司设计开发